Apoptosis of N-type neuroblastoma cells after differentiation with 9- cis-retinoic acid and subsequent washout

Journal of the National Cancer Institute

Volumn 89, Issue 6, 1997, Pages 446-452

  Lovat, Penny E ^a   Irving, Helen ^a   Annicchiarico Petruzzelli, Margherita ^b,c   Bernassola, Francesca ^b,c   Malcolm, Archie J ^a   Pearson, Andrew D J ^a   Melino, Gerry ^b,c   Redfern, Christopher P F ^a,d  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL DEATH; CELL DIFFERENTIATION; FLOW CYTOMETRY; LIGAND BINDING; LONG TERMINAL REPEAT; MORPHOGENESIS; NEUROBLASTOMA CELL; NONHUMAN; SCANNING ELECTRON MICROSCOPY; TRANSCRIPTION REGULATION;

EID: 0030960744     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.6.446     Document Type: Article

References (42)

1. Beckwith JB, Martin RF. Observations of the histopathology of neuroblastomas. J Pediatr Surg 1968;3:106-10.
2. Castleberry RP. Clinical and biological features in the prognosis and treatment of neuroblastoma. Curr Opin Oncol 1992;4:116-23.
3. Iwata M, Koshinaga T, Okabe I, Kurosu Y, Esumi M. Biological characteristics of neuroblastoma with spontaneous tumor reduction: a case report. J Pediatr Surg 1995;30:722-3.
4. Ciccarone V, Spengler BA, Meyers MB, Biedler JL, Ross RA. Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res 1989; 49:219-25.
5. Melino G, Annicchiarico-Petruzzelli M, Piredda L, Candi E, Gentile V, Davies PJ, et al. Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells. Mol Cell Biol 1994;14:6584-96.
6. Piacentini M, Annicchiarico-Petruzzelli M, Oliverio S, Piredda L, Biedler JL, Melino G. Phenotype-specific "tissue" transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: correlation with cell death by apoptosis. Int J Cancer 1992;52:271-8.
7. Sidell N. Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J Natl Cancer Inst 1982;68:589-96.
8. Finklestein JZ, Krailo MD, Lenarsky C, Ladisch S, Blair GK, Reynolds CP, et al. 13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Childrens Cancer Study Group. Med Pediatr Oncol 1992;20:307-11.
9. Smith MA, Adamson PC, Balis FM, Feusner J, Aronson L, Murphy RF, et al. Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer. J Clin Oncol 1992;10:1666-73.
10. Villablanca JG, Khan AA, Avramis VI, Seeger RC, Matthay KK, Ramsay NK, et al. Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation. J Clin Oncol 1995;13:894-901.
11. Lasorella A, Iavarone A, Israel MA. Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance. Cancer Res 1995;55:4711-6.
12. Stunnenberg HG. Mechanisms of transactivation by retinoic acid receptors. Bioessays 1993; 15:309-15.
13. Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell 1995;83:841-50.
14. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, et al. 9-cis Retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 1992;68:397-406.
15. Zhang XK, Lehmann J, Hoffmann B, Dawson MI, Cameron J, Graupner G, et al. Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature 1992;358:587-91.
16. Perlmann T, Jansson L. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-β and NURR1. Genes Dev 1995;9:769-82.
17. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 1995;9:1033-45.
18. Lovat PE, Lowis SP, Pearson AD, Malcolm AJ, Redfern CP. Concentration-dependent effects of 9-cis retinoic acid on neuroblastoma differentiation and proliferation in vitro. Neurosci Lett 1994;182:29-32.
19. Redfern CP, Lovat PE, Malcolm AJ, Pearson AD. Gene expression and neuroblastoma cell differentiation in response to retinoic acid: differential effects of 9-cis and all-trans retinoic acid. Eur J Cancer 1995;31A:486-94.
20. Han G, Chang B, Connor MJ, Sidell N. Enhanced potency of 9-cis versus all-trans-retinoic acid to induce the differentiation of human neuroblastoma cells. Differentiation 1995;59:61-9.
21. Miller WH Jr, Jakubowski A, Tong WP, Miller VA, Rigas JR, Benedetti F, et al. 9-cis Retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia. Blood 1995; 85:3021-7.
22. Kurie JM, Lee JS, Griffin T, Lippman SM, Drum P, Thomas MP, et al. Phase I trial of 9-cis retinoic acid in adults with solid tumors. Clin Cancer Res 1996;2:287-93.
23. Biedler JL, Helson L, Spengler BA. Morphology and growth, tumorigenicity and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 1973;33:2643-52.
24. Sjostrand FS. Electron microscopy of cells and tissues. New York: Academic Press, 1967.
25. Lovat PE, Pearson AD, Malcolm A, Redfern CP. Retinoic acid receptor expression during the in vitro differentiation of human neuroblastoma. Neurosci Lett 1993;162:109-13.
26. Piacentini M, Fesus L, Melino G. Multiple cell cycle access to the apoptotic death programme in human neuroblastoma cells. FEBS Lett 1993;320:150-4.
27. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
28. Wyllie AH, Duvall E. Cell death. In: McGee JO, Isaacson PG, Wright NA, editors. Oxford textbook of pathology, Vol. 1. Principles of pathology. Oxford: Oxford Univ Press, 1992: 141-56.
29. Nagy L, Thomazy VA, Shipley GL, Fesus L, Lamph W, Heyman RA, et al. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol Cell Biol 1995;15:3540-51.
30. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992;80:879-86.
31. El-Badry OM, Romanus JA, Helman LJ, Cooper MJ, Rechler MM, Israel MA. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J Clin Invest 1989;84:829-39.
32. Matthews CC, Feldman EL. Insulin-like growth factor I rescues SH-SY5Y human neuroblastoma cells from hyperosmotic induced programmed cell death. J Cell Physiol 1996;166:323-31.
33. Melino G, Stephanou A, Annicchiarico-Petruz-zelli M, Knight RA, Finazzi-Agro A, Lightman SL. Modulation of IGF-2 expression during growth and differentiation of human neuroblastoma cells: retinoic acid may induce IGF-2. Neurosci Lett 1993;151:187-91.
34. Ueno T, Suita S, Zaizen Y. Retinoic acid induces insulin-like growth factor II expression in a neuroblastoma cell line. Cancer Lett 1993; 71:177-82.
35. Babajko S, Binoux M. Modulation by retinoic acid of insulin-like growth-factor (IGF) and IGF binding protein expression in human SK-N-SH neuroblastoma cells. Eur J Endocrinol 1996;134:474-80.
36. Bernardini S, Cianfarani S, Spagnoli A, Annicchiarico-Petruzzelli M, Melino G, Massoud R, et al. Expression and down-regulation by retinoic acid of IGF binding protein-2 and -4 in medium from human neuroblastoma cells. J Neuroendocrinol 1994;6:409-13.
37. Rodriguez-Tebar A, Rohrer H. Retinoic acid induces NGF-dependent survival response and high-affinity NGF receptors in immature chick sympathetic neurons. Development 1991;112: 813-20.
38. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial-membrane protein that blocks programmed cell death. Nature 1990;348:334-6.
39. Zhang KZ, Westberg JA, Holtta E, Andersson LC. BCL2 regulates neural differentiation. Proc Natl Acad Sci U S A 1996;93:4504-8.
40. Hanada M, Krajewski S, Tanaka S, Cazals-Hatem D, Spengler BA, Ross RA, et al. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells. Cancer Res 1993;53:4978-86.
41. Redfern CP, Lovat PE, Malcolm AJ, Pearson AD. Differential effects of 9-cis and all-trans retinoic acid on the induction of retinoic acid receptor-beta and cellular retinoic acid-binding protein II in human neuroblastoma cells. Biochem J 1994;304:147-54.
42. Miller VA, Rigas JR, Benedetti FM, Verret AL, Tong WP, Kris MG, et al. Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid. Clin Cancer Res 1996;2:471-5.